Octasa MR (Modified release 400 and 800 mg)
Octasa MR is an Anti-inflammatory drug used in treating ulcerative colitis and Crohn’s ileocolitis once it has been brought under control. Mesalazine is the active ingredient in Octasa MR.
Ulcerative colitis is a disease of the colon and rectum that causes it to be inflamed (red and swollen)
Octasa acts at the site of the inflammation (terminal ileum in chron’s disease or the colon) to reduce inflammation.
Who should not use Octasa MR?
Do not use Octasa MR if you:
• Are allergic to mesalazine or any ingredients in this medication
• Are allergic to salicylate (aspirin or aspirin-like medications)
• you have severe kidney problems
• have severe liver problems
• Have hereditary problems such as galactose intolerance, glucose-galactose malabsorption.
How does Octasa MR work?
Octasa MR Tablets contain Mesalazine as its active ingredient. Mesalazine is an aminosalicylate that works in relieving inflammation in ulcerative colitis and chron’s disease.
The mode of action of mesalazine is not fully understood, but it reduces the inflammation of the intestine and by Extension the symptoms of the disease.
Modified release tablets contain special coatings that allow them to pass from the stomach to the intestine where its action is needed.
How do I use Octasa MR Tablets?
Octasa MR Tablets Are to be swallowed whole with a glass of water. Do not crush or chew modified-release tablets as this will damage the special coating that allows it to work in the intestine.
Can Pregnant or breastfeeding women use Octasa MR?
The safety of this medication has not been established during pregnancy and should only be used when the benefits outweigh the risk.
This medication passes into breast milk and should not be used during lactation. Inform your doctor before using any medication when you are pregnant or breastfeeding.